APA

Hong D. S., Janku F., Naing A., Falchook G. S., Piha-Paul S., Wheler J. J., Fu S., Tsimberidou A. M., Stecher M., Mohanty P., Simard J. & Kurzrock R. (20160216). Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer. : Investigational new drugs.

Chicago

Hong David S, Janku Filip, Naing Aung, Falchook Gerald S, Piha-Paul Sarina, Wheler Jennifer J, Fu Siqing, Tsimberidou Apostolia M, Stecher Michael, Mohanty Prasant, Simard John and Kurzrock Razelle. 20160216. Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer. : Investigational new drugs.

Harvard

Hong D. S., Janku F., Naing A., Falchook G. S., Piha-Paul S., Wheler J. J., Fu S., Tsimberidou A. M., Stecher M., Mohanty P., Simard J. and Kurzrock R. (20160216). Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer. : Investigational new drugs.

MLA

Hong David S, Janku Filip, Naing Aung, Falchook Gerald S, Piha-Paul Sarina, Wheler Jennifer J, Fu Siqing, Tsimberidou Apostolia M, Stecher Michael, Mohanty Prasant, Simard John and Kurzrock Razelle. Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer. : Investigational new drugs. 20160216.